Paratek antibiotic not inferior to current treatments: FDA staff [Reuters]
Paratek Pharmaceuticals, Inc. (PRTK)
Last paratek pharmaceuticals, inc. earnings: 2/25 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investor.paratekpharma.com
Company Research
Source: Reuters
Paratek antibiotic not inferior to current treatments: FDA staff | Reuters Reuters Staff 2 Min Read (Reuters) - A new antibiotic from Paratek Pharmaceuticals Inc is not inferior to current treatments for bacterial skin infections and pneumonia, U.S. Food and Drug Administration staff reviewers said on Monday. The comments come two days ahead of an advisory committee meeting that will evaluate the safety and effectiveness of the drug, omadacycline. The company’s shares rose 2 percent to $10 before the bell. However, FDA staff flagged safety concerns observed in the trial testing omadacycline as a treatment for community acquired bacterial pneumonia. "Of concern is the imbalance in mortality ... This mortality imbalance in a randomized controlled trial is noteworthy," staffers said here . There has been a push to develop new antibiotics as the United States faces growing concerns over resistance to current antibiotic treatments. At least 2 million people become infected annually with ba
Show less
Read more
Impact Snapshot
Event Time:
PRTK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRTK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRTK alerts
High impacting Paratek Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics